Greenup Street Wealth Management Invests in DexCom

The firm bought 34,043 shares of the medical device company's stock in Q4 2025.

Apr. 12, 2026 at 11:20am

Got story updates? Submit your updates here. ›

A close-up view of the complex, precision-engineered components of a continuous glucose monitoring device, captured in a high-contrast, industrial style that conveys the technological sophistication and importance of this medical innovation.Greenup Street Wealth Management's investment in DexCom's advanced glucose monitoring technology signals growing institutional confidence in the future of personalized diabetes care.San Diego Today

Greenup Street Wealth Management LLC, a financial advisory firm, disclosed in a recent SEC filing that it bought a new position in DexCom, Inc. (NASDAQ:DXCM) during the fourth quarter of 2025. The firm purchased 34,043 shares of the medical device company's stock, valued at approximately $2,259,000.

Why it matters

This investment highlights the growing interest and confidence in DexCom, a leading provider of continuous glucose monitoring (CGM) systems for people with diabetes. As the CGM market continues to expand, Greenup Street's move suggests they see long-term potential in DexCom's technology and market position.

The details

According to the 13F filing, Greenup Street Wealth Management LLC established a new stake in DexCom during the fourth quarter of 2025. The firm purchased 34,043 shares of the company's stock, valued at around $2,259,000 based on DexCom's share price at the time.

  • Greenup Street Wealth Management LLC bought the DexCom shares in the fourth quarter of 2025.
  • The 13F filing disclosing the investment was published on April 12, 2026.

The players

Greenup Street Wealth Management LLC

A financial advisory firm that manages investments and provides wealth management services.

DexCom, Inc.

A medical device company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for people with diabetes.

Got photos? Submit your photos here. ›

The takeaway

Greenup Street Wealth Management's investment in DexCom reflects the growing importance of CGM technology in diabetes management and the firm's belief in DexCom's market leadership and long-term growth potential.